![Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial - The Lancet Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial - The Lancet](https://www.thelancet.com/cms/asset/fef9e9bf-4d3b-46fa-908f-d757194411f7/gr1.gif)
Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial - The Lancet
![Women's Experiences with Self-Managed Misoprostol Abortions in Lagos State, Nigeria | Guttmacher Institute Women's Experiences with Self-Managed Misoprostol Abortions in Lagos State, Nigeria | Guttmacher Institute](https://www.guttmacher.org/sites/default/files/styles/max_1300x1300/public/462-759.png?itok=HYLiO7to)
Women's Experiences with Self-Managed Misoprostol Abortions in Lagos State, Nigeria | Guttmacher Institute
![Early Termination of Pregnancy with Mifepristone (RU 486) and the Orally Active Prostaglandin Misoprostol | NEJM Early Termination of Pregnancy with Mifepristone (RU 486) and the Orally Active Prostaglandin Misoprostol | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1993/nejm_1993.328.issue-21/nejm199305273282101/production/images/img_medium/nejm199305273282101_t1.jpeg)
Early Termination of Pregnancy with Mifepristone (RU 486) and the Orally Active Prostaglandin Misoprostol | NEJM
![Medication Abortion Restrictions Burden Women and Providers—and Threaten U.S. Trend Toward Very Early Abortion | Guttmacher Institute Medication Abortion Restrictions Burden Women and Providers—and Threaten U.S. Trend Toward Very Early Abortion | Guttmacher Institute](https://www.guttmacher.org/graphics/GPR/GPR-16-1-MedicationAbortionRegimensChart.png)
Medication Abortion Restrictions Burden Women and Providers—and Threaten U.S. Trend Toward Very Early Abortion | Guttmacher Institute
![Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial - The Lancet Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/8714109c-ea7a-463d-8691-ac82bf0826a4/gr3_lrg.gif)
Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial - The Lancet
![Early Termination of Pregnancy with Mifepristone (RU 486) and the Orally Active Prostaglandin Misoprostol | NEJM Early Termination of Pregnancy with Mifepristone (RU 486) and the Orally Active Prostaglandin Misoprostol | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1993/nejm_1993.328.issue-21/nejm199305273282101/production/images/img_medium/nejm199305273282101_t2.jpeg)
Early Termination of Pregnancy with Mifepristone (RU 486) and the Orally Active Prostaglandin Misoprostol | NEJM
Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa | PLOS ONE
![Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis | Scientific Reports Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-01892-0/MediaObjects/41598_2017_1892_Fig1_HTML.jpg)
Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis | Scientific Reports
![Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial - The Lancet Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/60c3d1ae-a9f1-4e0f-8264-fea757411d1f/gr2_lrg.gif)
Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial - The Lancet
![Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries - Journal of Obstetrics and Gynaecology Canada Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries - Journal of Obstetrics and Gynaecology Canada](https://www.jogc.com/cms/asset/5095240e-28f1-4524-b13e-30a3a20433b2/gr1.jpg)
Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries - Journal of Obstetrics and Gynaecology Canada
![Same-day mifepristone prior to second-trimester induction termination with misoprostol: A retrospective cohort study - ScienceDirect Same-day mifepristone prior to second-trimester induction termination with misoprostol: A retrospective cohort study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0010782421003826-gr1.jpg)